2024 Cancer Research & Diagnostics Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our experts for our Cancer Research & Diagnostics Digital Forum on June 18, 2024
Cancer Detection
Breast Cancer Detection App Gets FDA's Breakthrough Device Designation
Swathi Kodaikal, MSc
The application is the first of its kind to be recognized by the FDA
Seeking KRAS: An Optimized Protocol for Detecting KRAS Mutations
Thermo Fisher Scientific
Discover how Sanger sequencing helps detect KRAS mutations to inform oncological treatment and prognosis
December 6, 2023: Cancer & Genomics Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our speakers for our Cancer & Genomics Digital Forum on December 6, 2023
Blood Test to Detect Cancer Early in High-Risk Families
The Hospital for Sick Children
Liquid biopsies help extract and screen circulating tumor DNA for cancer-causing anomalies well in advance
Ultrasensitive Blood Test Detects Multi-Cancer-Specific Biomarker
Mass General Brigham
Novel blood test detects the highly specific ORF1p biomarker found in multiple cancers
Expanding Access to Genomic Testing for Cancer Patients
Morgana Moretti, PhD
Overcoming budget constraints can ensure equal access to genomic medicine to improve cancer care
Ultrasensitive MRD Assays for Rapid Turnaround Times
Jeremiah McDole, PhD
Liquid biopsies require a modern quantification approach to maximize sensitivity
Are Risk-Based MCED Tests the Future of Cancer Screening?
Swathi Kodaikal, MSc
Done early enough, personalized, patient data-driven multi-cancer screening will save lives. But are we there yet?
Urine-Based DNA Test Could Aid Early Bladder Cancer Detection
Swathi Kodaikal, MSc
Simple, noninvasive, accurate, and robust urine test uses aberrantly methylated genes as a biomarker